News & Updates
Filter by Specialty:
Vonoprazan on par with PPIs in BCQ therapy for H. pylori eradication
Vonoprazan-based bismuth-containing quadruple therapy (VBCQ) does better at eradicating Helicobacter pylori (H. pylori) than proton pump inhibitor (PPI)-based BCQ therapy (PBCQ), with similar adverse reactions and compliance, a study has shown.
Vonoprazan on par with PPIs in BCQ therapy for H. pylori eradication
08 Nov 2024
Disabling foot pain in PsA: Marker of worse PsA, significant burden on daily life
For Singaporeans with psoriatic arthritis (PsA), disabling foot pain appears to signal a more severe disease activity and exert a wide impact on daily life.
Disabling foot pain in PsA: Marker of worse PsA, significant burden on daily life
07 Nov 2024
ChatGPT may aid in diabetes, MetS management, but with caveat
Artificial intelligence (AI) chatbots, such as ChatGPT, can be used by clinicians as a resource for disease management and education, but researchers of a recent study urge users to consider the “gaps” seen in managing individuals with type 2 diabetes mellitus (T2DM) and metabolic syndrome (MetS).
ChatGPT may aid in diabetes, MetS management, but with caveat
07 Nov 2024
Menopausal hormone therapy prevents relapse in women with SSD
Use of menopausal hormone therapy (MHT) can avert psychosis relapse in women with schizophrenia or schizoaffective disorder (SSD) of menopausal age, suggests a recent study.
